Brief: Quince Therapeutics - On Dec 13, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

IRulya Therapeutics

16/12/2022 21:11

Dec 16 (Reuters) - Quince Therapeutics Inc  QNCX.O :
    * QUINCE THERAPEUTICS -  ON DEC 13, CO RECEIVED NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Further company coverage:  QNCX.O 
 ((Reuters.Briefs@thomsonreuters.com;))